Huma, a London, UK-based global healthcare AI company, raised over $80M in Series D funding.
Backers included AstraZeneca, Hat Technology Fund 4 by HAT SGR, HV Fund by Hitachi Ventures and Leaps by Bayer and others.
Alongside its Series D, Huma is also announcing the launch of its Huma Cloud Platform – a technology ecosystem designed to support its own digital health initiatives and to empower others to launch and scale their projects efficiently.
The company intends to use the funds to expand operations and its business reach.
Led by Dan Vahdat, Founder and CEO, Huma is a global healthcare AI company aiming to accelerate the adoption of digital solutions in care and research. Its modular platforms are used by more than 3,000 hospitals and clinics, with over 35 million screened users and 4 million registered users in healthcare, and has empowered over 800 studies supporting about 1 million participants across research. The company is renowned for its role in national healthcare projects worldwide, from the US and the UK to Germany, Greece, and Saudi Arabia, as well as collaborating with pharma companies.
Its platform offers no code configuration of regulated disease management tools for any therapeutic area, a library of pre-built modules and device connectivity capabilities, a cloud-agnostic framework for flexible hosting, readily available APIs and integration capabilities, the ability to host and deploy diagnostic and predictive AI algorithms, a marketplace, and more to advance digital-first care and research.
With this round, Huma has now raised over $300m.
FinSMEs
16/07/2024